Johnson & Johnson
JNJ
#24
Rank
$395.17 B
Marketcap
$164.16
Share price
-0.40%
Change (1 day)
0.77%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Revenue for Johnson & Johnson (JNJ)

Revenue in 2024 (TTM): $86.57 B

According to Johnson & Johnson's latest financial reports the company's current revenue (TTM) is $86.57 B. In 2023 the company made a revenue of $85.15 B a decrease over the revenue in the year 2022 that were of $91.14 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Johnson & Johnson from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $86.57 B1.66%
2023 $85.15 B-6.57%
2022 $91.14 B-2.8%
2021 $93.77 B13.55%
2020 $82.58 B0.64%
2019 $82.05 B0.59%
2018 $81.58 B6.71%
2017 $76.45 B6.34%
2016 $71.89 B2.59%
2015 $70.07 B-5.73%
2014 $74.33 B4.23%
2013 $71.31 B6.08%
2012 $67.22 B3.37%
2011 $65.03 B5.59%
2010 $61.58 B-0.5%
2009 $61.89 B-2.9%
2008 $63.74 B4.34%
2007 $61.09 B14.57%
2006 $53.32 B5.56%
2005 $50.51 B6.69%
2004 $47.34 B13.1%
2003 $41.86 B15.33%
2002 $36.29 B11.7%
2001 $32.49 B10.02%
2000 $29.53 B6.15%
1999 $27.82 B17.61%
1998 $23.65 B4.54%
1997 $22.62 B4.67%
1996 $21.62 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$55.64 B-35.73%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.47 B-27.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$48.86 B-43.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$51.13 B-40.93%๐Ÿ‡ซ๐Ÿ‡ท France
$21.38 B-75.29%๐Ÿ‡บ๐Ÿ‡ธ USA
$32.57 B-62.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$38.92 B-55.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$40.72 B-52.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$39.46 B-54.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
$27.80 B-67.89%๐Ÿ‡บ๐Ÿ‡ธ USA